Day: February 28, 2020

Press Release of 28th February 2020 – 20H00In accordance with the AFEP/MEDEF Corporate Governance Code actualized in January 2020 (art. 26.1) HERMES INTERNATIONAL discloses information on all elements, acquired or deferred, of its Executive Chairmen compensation, immediately following the Board meeting having established these elements.PrinciplesArticle 17 of the Articles of Association provides that each Executive Chairman shall be entitled to receive a statutory compensation, and possibly an additional compensation, the maximum amount of which is determined by the Shareholders’ Ordinary General Meeting with the unanimous approval of the active partners. The active partner determines each year the effective compensation of each of the Executive Chairmen within the limits of these ceilings. The active partner relies on the recommendations...

Communiqué du 28 février 2020- 20h00Conformément au Code de gouvernement d’entreprise AFEP / MEDEF actualisé en janvier 2020 (art 26.1) HERMES INTERNATIONAL rend publics tous les éléments de rémunération potentiels ou acquis des gérants immédiatement après la réunion du conseil les ayant arrêtés.PrincipesConformément à l’article 17 des statuts, chaque gérant a droit à une rémunération complémentaire et, éventuellement, à une rémunération statutaire, dont le montant maximal est fixé par l’Assemblée générale ordinaire, avec l’accord unanime des associés commandités. L’associé commandité décide de la rémunération effective de chacun des gérants chaque année dans la limite de ces plafonds. Il s’appuie sur les recommandations du Comité des rémunérations, des nominations, de la gouvernance et de la RSE (« Comité RNG-RSE ») et prend notamment...

PCTI designs, develops and manufactures standard and custom power electronic solutionsWEST PALM BEACH, FL, Feb. 28, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Ozop Surgical Corp. (OTCQB: OZSCD), (“Ozop” or the “Company”), today announces that it has signed a Binding Letter of Intent (the “LOI”) with Power Conversion Technologies, Inc. (“PCTI”), and Catherine Chis (“Chis”), the President of PCTI and its sole shareholder. Pursuant to the terms of the LOI, the Company will acquire 100% of the issued and outstanding common stock of PCTI from Chis. In conjunction with the LOI, Michael Chermak and Barry Hollander resigned as Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), respectively, and Brian Conway was named CEO and Interim CFO. Mr. Chermak remains as the sole Director of the CompanyPCTI operates in the very...

BROOKINGS, S.D., Feb. 28, 2020 (GLOBE NEWSWIRE) — Daktronics (NASDAQ-DAKT) of Brookings, South Dakota, announces it has participated in a Series A investment round in X Display Company (XDC). XDC creates and owns leading intellectual property (IP) and capabilities in microLED mass transfer technology.Series A investments will support XDC’s further development in microLED capabilities and applications. MicroLED technologies support Daktronics’ line of narrow pixel pitch LED displays and will enable solutions to move into the realm of less than 1-millimeter line spacings.“We see a lot of promise in microLEDs and the products we can produce with this technology,” said Daktronics President and CEO Reece Kurtenbach. “We believe XDC is a great partner, with IP and expertise in both the production processes and core technologies needed...

New York, Feb. 28, 2020 (GLOBE NEWSWIRE) —  Interpublic Group (NYSE: IPG) announced today that long-term Acxiom leader Chad Engelgau is being named Chief Executive Officer of the data, technology and marketing services company, which IPG acquired in late 2018. Dennis Self, who has served most recently as CEO, will stay on as an advisor for a period of transition to ensure continuity, before departing for a new venture. Acxiom will continue to report into Arun Kumar, the Chief Data and Technology Officer of IPG. For the past year, Mr. Engelgau has served as the Global Chief Data Strategist at Kinesso, the data intelligence unit that is part of IPG. For the prior thirteen years, Mr. Engelgau held a range of key leadership roles at Acxiom, ultimately overseeing data and identity product development as well as marketing and strategy...

BOTHELL, WA, Feb. 28, 2020 (GLOBE NEWSWIRE) — COCRYSTAL PHARMA, INC. (NASDAQ: COCP) (“Cocrystal” or the “Company”), a clinical stage biotechnology company discovering and developing novel antiviral therapeutics, announced today the closing of its previously announced registered direct offering with several institutional investors for 8,461,540 shares of its common stock at a purchase price of $1.30 per share, priced at-the-market under Nasdaq rules. The gross proceeds to the Company from the offering totaled approximately $11.0 million, before deducting placement agent fees and offering expenses.H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.Cocrystal intends to use the net proceeds for working capital and other general corporate purposes.The shares of common stock described above were offered...

UAB Ignitis Grupė, (hereinafter – the Company) identification code 301844044, registered office placed at Žvejų str. 14, Vilnius, Republic of Lithuania. The total nominal value of issued bonds 600 000 000 EUR; ISIN codes XS1646530565; XS1853999313.Preliminary financial data of Ignitis Group for 1 month of 2020:In January 2020, Ignitis Group generated revenue of EUR 111.5 million, which is 13.2% less compared to a respective period of 2019 (EUR 128.4 million). The Group’s revenue has decreased due to reduced volume of sold gas for business customers which was caused by unusually warm winter and lower gas supply tariffs for household customers.The adjusted EBITDA indicator of the Group in January 2020 was equal to EUR 32.2 million, i.e. 7% more compared to a respective period of 2019 (EUR 30.1 million). The adjusted EBITDA indicator...

UAB „Ignitis grupė“ (toliau – „Ignitis grupė“ ir Bendrovė), juridinio asmens kodas: 301844044, registruotos buveinės adresas: Žvejų g. 14, Vilnius. Bendra UAB „Ignitis grupė“ išleistų obligacijų nominali vertė 600 000 000 EUR; ISIN kodai: XS1646530565; XS1853999313.2020 metų 1 mėnesio preliminarūs „Ignitis grupės“ finansiniai duomenys:„Ignitis grupės“ pajamos 2020 m. sausio mėn. siekė 111,5 mln. eurų ir buvo 13,2 proc. mažesnės palyginus su atitinkamu laikotarpiu 2019 m. (128,4 mln. eurų). Grupės pajamų mažėjimą lėmė dėl neįprastai šiltos žiemos sumažėję parduotų dujų kiekiai verslo klientams bei mažesni dujų tiekimo tarifai buitiniams vartotojams.Grupės koreguotas EBITDA rodiklis 2020 m. sausio mėn. siekė 32,2 mln. eurų – 7,0 proc. daugiau nei atitinkamu laikotarpiu 2019 m. (30,1 mln. eurų). Rodiklio augimą lemia geresnis elektros bei...

UAB Ignitis Grupė, (hereinafter – the Company) identification code 301844044, registered office placed at Žvejų str. 14, Vilnius, Republic of Lithuania. The total nominal value of issued bonds 600 000 000 EUR; ISIN codes XS1646530565; XS1853999313.In 2019, international energy company Ignitis Group recorded growth of all key financial indicators.  The Group‘s revenue, net profit and EBITDA – all grew if compared to the year 2018.Last year total revenue of Ignitis Group grew by 0.5% and amounted to EUR 1.095 billion. This growth was caused by higher revenue from energy distribution, green and strategic generation segments which counterbalanced decreased revenue share from the commercial organisation segment.After eliminating regulatory effects, the Group’s adjusted EBITDA increased by 21.7% and totaled EUR 259 million, compared to EUR...

UAB „Ignitis grupė“ (toliau – Bendrovė),  juridinio asmens kodas: 301844044, registruotos buveinės adresas: Žvejų g. 14, Vilnius. Bendra UAB „Ignitis grupė“ išleistų obligacijų nominali vertė 600 000 000 EUR; ISIN kodai: XS1646530565; XS1853999313.2019 metais tarptautinė energetikos bendrovė „Ignitis grupė“ fiksavo visų pagrindinių finansinių rodiklių augimą. Lyginant su 2018 metais, padidėjo tiek bendrosios grupės pajamos, tiek grynasis pelnas ir EBITDA.Iš viso „Ignitis grupės“ pajamų suma praėjusiais metais išaugo 0,5 proc., iki 1,095 mlrd. EUR. Tokį pokytį lėmė pajamų iš energijos skirstymo, žaliosios ir strateginės gamybos augimas, kuris atsvėrė sumažėjusią pajamų dalį iš grupės komercinės organizacijos segmento. Eliminavus reguliacinius efektus, koreguotas grupės pelnas prieš palūkanas, mokesčius, nusidėvėjimą bei amortizaciją (EBITDA)...